Independence, But Not Isolation: Panel Of FDA Commissioners Reflect On Role Of Dialogue With External Stakeholders
US FDA Commissioner Scott Gottlieb and three former agency heads tout value of deliberation with broader scientific community, but also agency's ability to make regulatory decisions independently.
You may also be interested in...
External Collaboration At US FDA Is More Difficult Than At NIH, Sharpless Says
Acting US FDA commissioner Norman Sharpless outlines some key differences between his new position and his former role at the NCI.
Gottlieb On Gene Therapies: 'Very Seductive' To Think About Accelerated Approval Pathway
Accelerated approval would help agency monitor gene therapies for durability and off-target effects, US FDA commissioner says.
Real World Evidence: Between 'Nirvana' And Electronic Roadblocks
US FDA's Jonathan Jarow says it will be up to pharma industry to get right data into electronic health records.